OpenVSafe by OpenVAERS
Search V-safe

HM6-13272-01371

3 vaccinations 11 coded responses 28 check-ins 4 free-text entries 3 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
917 / CA
Registered
2021-03-30
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2070023 (opens in a new window) high 11 / 11 — 7 of 9 VAERS symptoms same dose (3) CA matches 2021-10-20 / 2021-10-21 / 2022-01-27
received the same day as the last call
case 80644

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-30
    Registered in v-safe
  2. 2021-03-30
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea — Feeling: Poor · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Joint pains, Nausea
    Adult check-in
  5. 2021-04-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Rhinorrhoea — Feeling: Fair · Fatigue or tiredness
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-06
    Survey response — day 7, dose 1
    MedDRA: Rhinorrhoea — Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Runny nose
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-15
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-04-20
    Dose 2 — Pfizer-BioNTech
  9. 2021-04-20
    Health check-in — day 0, dose 2
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  10. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  11. 2021-04-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  12. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Chills, Headache, Fatigue or tiredness
    Adult check-in
  13. 2021-04-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Syncope — Feeling: Good · Fatigue or tiredness, Nausea
    Free text: Mareo y syncope
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-04-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-27
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  16. 2021-05-06
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-05-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-05-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-25
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  20. 2021-06-01
    Survey response — day 42, dose 2
    MedDRA: Abdominal pain upper, Chills, Diarrhoea, Headache, Nausea — Feeling: Good · Be unable to do your normal daily activities
    MedDRA releases: 2021-09,2023-04,2024-11
  21. 2021-07-22
    Survey response — 3 months, dose 2
    MedDRA: Diarrhoea, Nausea, Pain — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  22. 2021-10-20
    Dose 3 — Pfizer-BioNTech
  23. 2021-10-25
    Survey response — days 1–6 daily, dose 3
    MedDRA: Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    MedDRA releases: 2024-11
  24. 2021-10-25
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Emergency room or emergency department visit · 1 call case(s)
  25. 2021-10-26
  26. 2021-10-27
    Survey response — day 7, dose 3
    MedDRA: Chest pain, Cough, Oropharyngeal pain — Feeling: Fair · Site: Pain, Itching · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  27. 2021-11-03
    Survey response — day 14, dose 3
    MedDRA: Abdominal pain upper, Diabetes mellitus inadequate control, Fatigue, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    MedDRA releases: 2024-11
  28. 2021-11-03
    Report sent to call center — day 14, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  29. 2021-11-08
  30. 2021-11-11
  31. 2021-11-12
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-11-17
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-11-24
    Health check-in — day 35, dose 3
    Feeling: Fair
    Adult check-in
  34. 2021-12-04
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-01-19
    Survey response — 3 months, dose 3
    MedDRA: Adverse reaction — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    MedDRA releases: 2024-11
  36. 2022-01-19
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  37. 2022-01-22
  38. 2022-01-27
  39. 2022-01-27
  40. 2022-01-27
    Call successful
    Completed over the phone
  41. 2022-04-20
    Survey response — 6 months, dose 3
    MedDRA: Cough, Pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11
  42. 2022-10-20
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-30Pfizer-BioNTech
22021-04-20Pfizer-BioNTech
32021-10-20Pfizer-BioNTech No

Call center

3 call center cases

3 successful

VAERS report filed, before or during a call: 3

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-02

Systemic reaction (other): Runny nose

2021-04-05

Systemic reaction (other): Runny nose

Release 7 — day 7, dose 1

2021-04-06

Systemic reaction (other): Runny nose

Release 7 — days 1–6 daily, dose 2

2021-04-25

Systemic reaction (other): Mareo y syncope

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain upper ✓ ✓ ✓
SDAdverse reaction · · ✓
SDChills ✓ ✓ ✓
SDCough · · ✓
SDDiabetes mellitus inadequate control · · ✓
SDDiarrhoea ✓ ✓ ✓
SDFatigue · · ✓
SDHeadache ✓ ✓ ✓
SDNausea ✓ ✓ ✓
SDPain · · ✓
SDVomiting · · ✓
SROChest pain · · ✓
SROCough · · ✓
SRODizziness ✓ ✓ ✓
SROOropharyngeal pain · · ✓
SRORhinorrhoea ✓ ✓ ✓
SROSyncope ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release